Editor-in-Chief of Journal of Transdisciplinary Biomedicine (JTB), Assoc. Prof. Cheah Yoke Kqueen as well as EnPress Publisher LLC will like to join hands to invite all authors and researchers to submit manuscripts to our recently launched journal.

JTB launched as Hybrid Open Access journal providing a platform for authors to choose the option to publish as Subscription-Based article or Open Access article. The advantage of Subscription-Based article is publication fee will be waived for the article.

JTB is a publication on interdisciplinary field of Biomedical Sciences that target on molecular biology activity and mechanism, with or without interactions between DNA, RNA, genes and proteins. These biosynthesises in the field of:

• Bioimaging
• Bioengineering
• Diagnostics & Prognostics
• Therapeutics
• Biophysics & Chemistry
• Pharmacology
• Bioinformatics
• Clinical sciences

The scope of the journal is to covers in vitro, ex vivo, in vivo biomedical sciences application in various disciplines

The journal rendering support to authors by:

• Publication fee/Article Processing Charge will be waived for authors choose Subscription-Based Article.
• Author may choose to publish open access by paying the publication fee.
• Immediate response, minimal time for processing and publication.
• Authors may self-archive at stipulated time to increase visibility.

All manuscripts will screen through a high standard protocol of double blind peer review. Each manuscript will be reviewed by at least 2 qualified reviewers from either Editorial Board or external penal expert based on the manuscript title. However, the final decision will be under Editor-in-Chief.

The manuscript management adhere to “Code of Conduct for Journal Editors and Code of Conduct for Publishers” and Best Practise as stipulated by Committee on Publication Ethics (COPE) to prevent misconduct of research papers.

Submission can be made through the submit manuscript Online Submission and Author Guidelines will assist in your submission process.